Mikyung Kang

6PUBLICATIONS
32CO-AUTHORS
Rehabilitation engineeringCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2023
Publisher Correction: Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model.

Sagang Koo, Hee Su Sohn, Tae Hee Kim

|Oct 26, 2023
Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model.

Sagang Koo, Hee Su Sohn, Tae Hee Kim

|Jun 08, 2023
Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin-Drug Conjugate Response.

Huiyu Hu, Thomas S C Ng, Mikyung Kang

|Sep 12, 2021
Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer Therapy.

Mikyung Kang, Seong Ho Lee, Miji Kwon

|Aug 20, 2020
T-Cell-Mimicking Nanoparticles for Cancer Immunotherapy.

Mikyung Kang, Jihye Hong, Mungyo Jung

|Jun 05, 2020
Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair.

Ju-Ro Lee, Bong-Woo Park, Jonghoon Kim

Pageof 1

Frequent Collaborators

5 joint publications

Byung-Soo Kim

3 joint publications

Taeghwan Hyeon

2 joint publications

Tae Hee Kim

2 joint publications

Ok Kyu Park